Regional
Rappahannock EMS Council
The current listed document is more than 24 months old and may be outdated.
Drugs and doses32
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride6
Adenosine
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 2.5 mg | NEB | not captured | standing | pages 105, 106 · source |
| Cyanide poisoning | peds | 2.5 mg | NEB | not captured | standing | pages 105, 106 · source |
| Hyperkalemia | adult | 10–20 mg | NEB | not captured | standing | pages 35, 69, 114, 120 · source |
| Other | adult | 2.5 mg | NEB | not captured | standing | pages 59, 114 · source |
| Other | peds | 2.5 mg | NEB | not captured | standing | pages 59, 114 · source |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 34, 36, 37, 115 · source |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 34, 36, 37, 115 · source |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | pages 34, 41, 115, 116 · source |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 53, 117 · source |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 39, 40, 118 · source |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 39, 40, 118 · source |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM | not captured | standing | pages 81, 118 · source |
| Organophosphate poisoning | peds | 0.04 mg/kg | IV/IO/IM | not captured | standing | pages 81, 118 · source |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 120 · source |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 35, 120 · source |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 35, 120 · source |
D–F Dextrose, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl, Furosemide8
Dextrose
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 43, 99, 122 · source |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Dystonic reaction | adult | 25 mg | IV/IO/IM | not captured | standing | pages 51, 123 · source |
| Other | adult | 25 mg | IV/IO/IM | not captured | standing | pages 45, 123 · source |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 51, 123 · source |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 51, 123 · source |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 45, 123 · source |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 39, 51, 53, 55, 124 · source |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 51, 125 · source |
| Anaphylaxis | adult | 0.3 mg | IV | not captured | standing | pages 51, 125 · source |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 51, 125 · source |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 39, 40, 125, 127 · source |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 39, 40, 125, 127 · source |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 36, 37, 125 · source |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 36, 37, 125 · source |
| CHF / pulmonary edema | adult | 5–20 mcg | IV/IO | not captured | standing | pages 58, 125 · source |
| Head injury / TBI | adult | 5–20 mcg | IV/IO | not captured | standing | pages 68, 125 · source |
| Other | adult | 0.3 mg | IM | not captured | standing | pages 59, 125 · source |
| Other | adult | 3 mL | NEB | not captured | standing | pages 59, 125 · source |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | pages 59, 125 · source |
| Other | peds | 3 mL | NEB | not captured | standing | pages 59, 125 · source |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 46, 128 · source |
| Procedural sedation | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 46, 128 · source |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 79, 128 · source |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 79, 128 · source |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mcg/kg | IV/IM/IN | not captured | standing | pages 69, 129 · source |
| Agitation | peds | 2 mcg/kg | IV/IM/IN | not captured | standing | pages 69, 129 · source |
| Burns | adult | 1–2 mcg/kg | IV/IM/IN | not captured | standing | pages 66, 129 · source |
| Burns | peds | 1–3 mcg/kg | IV/IM/IN | not captured | standing | pages 66, 129 · source |
| Other | adult | 1–1.5 mcg/kg | IV | not captured | standing | pages 69, 129 · source |
| Other | peds | 1–1.5 mcg/kg | IV | not captured | standing | pages 69, 129 · source |
| Mild to moderate pain | adult | 0.5–1 mcg/kg | IV/IM/IN | not captured | standing | pages 49, 129 · source |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IV/IM/IN | not captured | standing | pages 49, 129 · source |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.5 mg/kg | IV | not captured | standing | pages 58, 131 · source |
G–L Glucagon, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Lidocaine6
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IM/SQ | not captured | standing | pages 52, 60, 132 · source |
Hydroxocobalamin
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 0.5 mg | NEB | not captured | standing | pages 105, 106 · source |
| Cyanide poisoning | peds | 0.5 mg | NEB | not captured | standing | pages 105, 106 · source |
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 59, 119 · source |
| Other | peds | 0.5 mg | NEB | not captured | standing | pages 59, 119 · source |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg/kg | IV | not captured | standing | pages 46, 69, 134 · source |
| Agitation | adult | 2 mg/kg | IM | not captured | standing | pages 46, 69, 134 · source |
| Agitation | peds | 1–2 mg/kg | IV | not captured | standing | pages 46, 69, 134 · source |
| Agitation | peds | 2–4 mg/kg | IM | not captured | standing | pages 46, 69, 134 · source |
| Mild to moderate pain | adult | 0.25–0.5 mg/kg | IV | not captured | standing | pages 49, 66, 134 · source |
| Mild to moderate pain | peds | 0.25–0.5 mg/kg | IV | not captured | standing | pages 49, 66, 134 · source |
| RSI induction | adult | 2 mg/kg | IV | not captured | standing | pages 79, 134 · source |
Ketorolac
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 34, 36, 37, 136 · source |
| Cardiac arrest | peds | 1 mg/kg | IV/IO | not captured | standing | pages 34, 36, 37, 136 · source |
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 34, 136, 137 · source |
| Other | adult | 20–40 mg | IO | not captured | standing | pages 80, 136 · source |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | pages 80, 136 · source |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Naloxone, Nitroglycerin, Ondansetron7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 50 mg/kg | IV | not captured | standing | pages 59, 138, 139 · source |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | pages 59, 138, 139 · source |
| Eclampsia / pre-eclampsia | adult | 2–4 g | IV/IO | not captured | standing | pages 61, 139 · source |
| Other | adult | 1–2 g | IV/IO | not captured | standing | pages 35, 138 · source |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | pages 35, 138 · source |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV | not captured | standing | pages 51, 59, 140 · source |
| Allergic reaction | peds | 2 mg/kg | IV | not captured | standing | pages 51, 59, 140 · source |
| Respiratory distress | adult | 125 mg | IV | not captured | standing | pages 59, 140 · source |
| Respiratory distress | peds | 2 mg/kg | IV | not captured | standing | pages 59, 140 · source |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5 mg | IV/IO | not captured | standing | pages 43, 99, 143 · source |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 45, 46, 141 · source |
| Agitation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 45, 46, 141 · source |
| Other | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 79, 141 · source |
| Other | adult | 2 mg | IV/IN | not captured | standing | pages 61, 141 · source |
| Other | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 69, 141 · source |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 69, 141 · source |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 45, 46, 141 · source |
| Seizure | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 60, 141 · source |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 60, 141 · source |
Naloxone
Nitroglycerin
P–R Pralidoxime, Rocuronium2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | pages 81, 147 · source |
S–Z Sodium Bicarbonate, Tranexamic Acid, Vecuronium3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 100 mEq | IV | not captured | standing | pages 69, 148 · source |
| Hyperkalemia | adult | 50–100 mEq | IV | not captured | standing | pages 35, 148 · source |
| Hyperkalemia | peds | 1–2 mEq/kg | IV | not captured | standing | pages 35, 148 · source |
| Tricyclic overdose | adult | 50–100 mEq | IV | not captured | standing | pages 35, 148 · source |
| Tricyclic overdose | peds | 1–2 mEq/kg | IV | not captured | standing | pages 35, 148 · source |
Tranexamic Acid
Cite this
Rappahannock EMS Council, United States EMS Protocol Census. 111 dose entries, effective 2022-08-17.
https://protoquiz.com/census/agencies/rappahannock-ems-council/
The census is free and not for sale. Only public agencies are named.